Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An integrated pan-cancer analysis of TFAP4 aberrations and the potential clinical implications for cancer immunity.

Journal of cellular and molecular medicine - 1 Feb 2021

Liu Jian-Nan, Kong Xiang-Shuo, Sun Ping, Wang Rui, Li Wang, Chen Qi-Feng

Abstract excerpt

Studies have shown that transcription factor activating enhancer binding protein 4 (TFAP4) plays a vital role in multiple types of cancer; however, the TFAP4 expression profile is still unknown, as is its value within the human pan-cancer analysis. The present study comprehensively analysed TFAP4 expression patterns from 33 types of malignancies, along with the significance of TFAP4 for prognosis prediction and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Computational Biology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Immunity

Share to Immunomodulation

Share to Lymphocytes, Tumor-Infiltrating

Share to Proportional Hazards Models

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 33373169
DOI: 10.1111/jcmm.16147
PMCID: PMC7882993

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An integrated pan-cancer analysis of TFAP4 aberrations and the potential clinical implications for cancer immunity.PMID 33373169Read ↗

Comprehensive analysis of the prognostic value of PEBP4 in pan-cancersSemantic proximity Read ↗

A pan-cancer analysis of FAT atypical cadherin 4 (FAT4) in human tumorsSemantic proximity Read ↗

Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer AnalysisSemantic proximity Read ↗

Comprehensive analysis of pan‐cancer reveals potential of ASF1B as a prognostic and immunological biomarkerSemantic proximity Read ↗

A comprehensive pan-cancer examination of transcription factor MAFF: Oncogenic potential, prognostic relevance, and immune landscape dynamicsSemantic proximity Read ↗

Pan-cancer analysis reveals the oncogenic and immunomodulatory roles of PTGFRN across human cancers.Semantic proximity Read ↗

Identifying the oncogenic roles of FAP in human cancers based on systematic analysisSemantic proximity Read ↗

KIF11 As a Potential Pan‐Cancer Immunological Biomarker Encompassing the Disease Staging, Prognoses, Tumor Microenvironment, and Therapeutic ResponsesSemantic proximity Read ↗

Identification of FAT4 Mutation as a Prognostic Marker for Overall Survival and Immune Landscape in Lung AdenocarcinomaSemantic proximity Read ↗

Unraveling the Expression Patterns of Immune Checkpoints Identifies New Subtypes and Emerging Therapeutic Indicators in Lung AdenocarcinomaSemantic proximity Read ↗

Analysis of the correlation between the expression of non-classical E2F transcription factor 8 (E2F8) in pan-cancer and prognosis and immune infiltrationSemantic proximity Read ↗

A Pan-Cancer Analysis of FAT Atypical Cadherin 4 (FAT4) in Human TumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.